AIDS Wasting in Women: Anabolic Effects of Testosterone
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The study is a 6 month, placebo-controlled study of transdermal testosterone for women with
HIV-associated weight loss. Women with AIDS wasting have been found to have low testosterone
levels. This study is designed to test the efficacy of physiologic testosterone dosing to
improve weight, muscle mass and quality of life indices, including energy level, appetite and
libido, in androgen deficient women with AIDS wasting. After 6 months, all women receive open
label transdermal testosterone for an additional 6 months.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)